EMEA-001271-PIP01-12-M01 - paediatric investigation plan

travoprost

Key facts

• Invented name:
  • Travatan
  • Travatan
• Active Substance:
  travoprost
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0298/2013
• PIP number:
  EMEA-001271-PIP01-12-M01
• Pharmaceutical form(s):
  Eye drops, solution
• Condition(s) / indication(s):
  Treatment of glaucoma
• Route(s) of administration:
  Ocular use
• Contact for public enquiries:

  Alcon Laboratories (UK) Ltd.

  United Kingdom; [e-mail]; Tel. [phone]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  29/11/2013
• Compliance procedure number:
  EMEA-001271-PIP01-12-M01
• Compliance opinion date:
  23/05/2014
• Compliance outcome:
  Positive

Decision

P/0298/2013: EMA decision of 29 November 2013 on the acceptance of a modification of an agreed paediatric investigation plan for travoprost (Travatan) (EMEA-001271-PIP01-12-M01)

AdoptedReference Number: EMA/647635/2013